Pascal Soriot Britain city Oxford covid-19 testing pandemic vaccine Coronavirus Pascal Soriot Britain city Oxford

Covid vaccine race won’t decide AstraZeneca's future

Reading now: 180
www.livemint.com

AstraZeneca Plc boss Pascal Soriot recently said he hoped there’d be more than one successful vaccine against Covid-19 given the sheer quantities required.

His company’s shares have soared this year largely on hopes for the University of Oxford shot that it’s helping test, manufacture and eventually distribute.

But on Monday AstraZeneca’s investors didn’t celebrate encouraging data from rival Pfizer Inc.’s coronavirus vaccine. The UK firm wasn’t the only drugmaker to see its shares fall, but the decline in its stock looks like an expression of disappointment it might not “win" the race to land a preventative drug.In reality, the ambition to develop a vaccine has never been a good reason to buy into AstraZeneca.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA